Globus Medical ROE 2012-2026 | GMED
Current and historical return on equity (ROE) values for Globus Medical (GMED) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Globus Medical ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-06-30 | $0.54B | $4.62B | 11.61% |
| 2026-03-31 | $0.59B | $4.50B | 13.04% |
| 2025-12-31 | $0.54B | $4.34B | 12.40% |
| 2025-09-30 | $0.42B | $4.24B | 10.00% |
| 2025-06-30 | $0.36B | $4.16B | 8.59% |
| 2025-03-31 | $0.19B | $4.08B | 4.56% |
| 2024-12-31 | $0.10B | $4.04B | 2.58% |
| 2024-09-30 | $0.09B | $3.99B | 2.31% |
| 2024-06-30 | $0.04B | $4.02B | 1.02% |
| 2024-03-31 | $0.07B | $3.52B | 1.90% |
| 2023-12-31 | $0.12B | $3.02B | 4.07% |
| 2023-09-30 | $0.16B | $2.48B | 6.36% |
| 2023-06-30 | $0.20B | $1.88B | 10.87% |
| 2023-03-31 | $0.20B | $1.81B | 11.13% |
| 2022-12-31 | $0.19B | $1.77B | 10.71% |
| 2022-09-30 | $0.16B | $1.75B | 8.87% |
| 2022-06-30 | $0.16B | $1.74B | 8.93% |
| 2022-03-31 | $0.14B | $1.72B | 8.25% |
| 2021-12-31 | $0.15B | $1.67B | 8.95% |
| 2021-09-30 | $0.19B | $1.61B | 11.64% |
| 2021-06-30 | $0.18B | $1.53B | 12.02% |
| 2021-03-31 | $0.12B | $1.46B | 8.31% |
| 2020-12-31 | $0.10B | $1.41B | 7.26% |
| 2020-09-30 | $0.10B | $1.38B | 6.89% |
| 2020-06-30 | $0.09B | $1.36B | 6.54% |
| 2020-03-31 | $0.15B | $1.35B | 10.98% |
| 2019-12-31 | $0.16B | $1.32B | 11.77% |
| 2019-09-30 | $0.15B | $1.26B | 11.56% |
| 2019-06-30 | $0.14B | $1.21B | 11.79% |
| 2019-03-31 | $0.15B | $1.17B | 12.87% |
| 2018-12-31 | $0.16B | $1.11B | 14.11% |
| 2018-09-30 | $0.14B | $1.06B | 13.61% |
| 2018-06-30 | $0.14B | $1.01B | 13.41% |
| 2018-03-31 | $0.12B | $0.96B | 12.41% |
| 2017-12-31 | $0.11B | $0.92B | 11.75% |
| 2017-09-30 | $0.11B | $0.89B | 12.20% |
| 2017-06-30 | $0.11B | $0.85B | 12.65% |
| 2017-03-31 | $0.11B | $0.82B | 12.76% |
| 2016-12-31 | $0.10B | $0.79B | 13.12% |
| 2016-09-30 | $0.12B | $0.76B | 15.46% |
| 2016-06-30 | $0.12B | $0.73B | 16.18% |
| 2016-03-31 | $0.12B | $0.70B | 16.68% |
| 2015-12-31 | $0.11B | $0.66B | 17.08% |
| 2015-09-30 | $0.10B | $0.63B | 16.38% |
| 2015-06-30 | $0.10B | $0.60B | 16.69% |
| 2015-03-31 | $0.10B | $0.57B | 17.01% |
| 2014-12-31 | $0.09B | $0.54B | 17.15% |
| 2014-09-30 | $0.09B | $0.51B | 16.73% |
| 2014-06-30 | $0.08B | $0.49B | 17.03% |
| 2014-03-31 | $0.07B | $0.46B | 14.97% |
| 2013-12-31 | $0.07B | $0.44B | 15.54% |
| 2013-09-30 | $0.07B | $0.42B | 16.34% |
| 2013-06-30 | $0.06B | $0.40B | 16.19% |
| 2013-03-31 | $0.08B | $0.37B | 20.53% |
| 2012-12-31 | $0.07B | $0.34B | 21.53% |
| 2012-09-30 | $0.07B | $0.32B | 21.10% |
| 2012-06-30 | $0.07B | $0.23B | 30.02% |
| 2012-03-31 | $0.06B | $0.15B | 42.47% |
| 2011-12-31 | $0.06B | $0.07B | 79.43% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.173B | $2.939B |
| Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $226.884B | 25.75 |
| Intuitive Surgical (ISRG) | United States | $133.518B | 45.26 |
| Edwards Lifesciences (EW) | United States | $49.242B | 30.43 |
| IQVIA Holdings (IQV) | United States | $43.729B | 23.39 |
| Waters (WAT) | United States | $40.283B | 29.97 |
| IDEXX Laboratories (IDXX) | United States | $40.144B | 35.83 |
| Alcon (ALC) | Switzerland | $33.505B | 20.78 |
| DexCom (DXCM) | United States | $31.955B | 33.21 |
| Mettler-Toledo (MTD) | United States | $25.762B | 28.65 |
| STERIS (STE) | Ireland | $20.832B | 20.50 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.759B | 0.00 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| Coloplast (CLPBY) | Denmark | $14.762B | 17.70 |
| Penumbra (PEN) | United States | $12.599B | 83.08 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.279B | 8.59 |
| Glaukos (GKOS) | United States | $10.092B | 0.00 |
| Masimo (MASI) | United States | $9.578B | 30.69 |
| SARTORIUS (SSSGY) | Germany | $7.521B | 43.67 |
| Sysmex ADR (SSMXY) | Japan | $7.390B | 27.95 |
| Teleflex (TFX) | United States | $5.521B | 14.89 |
| LivaNova (LIVN) | United Kingdom | $4.442B | 22.46 |
| Integer Holdings (ITGR) | United States | $4.287B | 19.86 |
| Pulse Biosciences (PLSE) | United States | $3.752B | 0.00 |
| Veracyte (VCYT) | United States | $3.313B | 27.11 |
| TransMedics (TMDX) | United States | $2.967B | 43.58 |
| AxoGen (AXGN) | United States | $2.354B | 0.00 |
| UFP Technologies (UFPT) | United States | $2.153B | 27.17 |
| Elekta AB (EKTAY) | Sweden | $1.883B | 17.62 |
| Nihon Kohden (NHNKY) | Japan | $1.694B | 15.52 |
| Alphatec Holdings (ATEC) | United States | $1.677B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $1.301B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.222B | 6.36 |
| Artivion (AORT) | United States | $1.217B | 46.24 |
| PROCEPT BioRobotics (PRCT) | United States | $1.204B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.171B | 27.77 |
| Tandem Diabetes Care (TNDM) | United States | $1.170B | 0.00 |
| OPKO Health (OPK) | United States | $1.164B | 0.00 |
| IRadimed (IRMD) | United States | $1.055B | 46.11 |
| Anteris Technologies Global (AVR) | Australia | $0.850B | 0.00 |
| SiBone (SIBN) | United States | $0.829B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.753B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.680B | 16.37 |
| AngioDynamics (ANGO) | United States | $0.641B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.583B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.570B | 1644.00 |
| Tactile Systems Technology (TCMD) | United States | $0.511B | 20.90 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.448B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.420B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.411B | 0.00 |
| 908 Devices (MASS) | United States | $0.402B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.371B | 0.00 |
| Mobia Medical (MOBI) | United States | $0.334B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Treace Medical Concepts (TMCI) | United States | $0.301B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.266B | 0.00 |
| RxSight (RXST) | United States | $0.254B | 0.00 |
| Neuronetics (STIM) | United States | $0.221B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.159B | 0.00 |
| FocalTherics (FOCL) | France | $0.154B | 0.00 |
| Inogen (INGN) | United States | $0.139B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.124B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Hyperfine (HYPR) | United States | $0.085B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.083B | 0.00 |
| CVRx (CVRX) | United States | $0.080B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 23.27 |
| DarioHealth (DRIO) | United States | $0.069B | 0.00 |
| Positron (POSC) | United States | $0.059B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.059B | 0.00 |
| Envoy Medical (COCH) | United States | $0.056B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.048B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| InspireMD (NSPR) | United States | $0.038B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.036B | 0.00 |
| PAVmed (PAVM) | United States | $0.035B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.032B | 0.00 |
| Accuray (ARAY) | United States | $0.029B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.010B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.009B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.007B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| NexGel (NXGL) | United States | $0.003B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |